Skip to main content
  1. Right Decisions
  2. Neurology pathways - including headache
  3. Back
  4. GP factsheets
  5. Probable mild axonal peripheral neuropathy
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Probable mild axonal peripheral neuropathy

Warning

Introduction

This fact sheet provides information on how to treat patients with Probable Mild Axonal Peripheral
Neuropathy with different symptoms, situations and circumstances.

Please note this fact sheet is only designed as a brief summary of management.

 

Peripheral neuropathy

Peripheral neuropathy has a long list of causes, some of which are treatable, such as diabetes, toxic or autoimmune disorders. Other causes, such as genetic, are useful to identify even if there is no current treatment. In practice, a large proportion of peripheral neuropathic symptoms are either not due to an identifiable peripheral neuropathy, or a consequence of axonal degeneration, especially in older people. These patients usually follow a benign course, do not become disabled and often do not need to see a neurologist. This fact sheet is aimed at providing information for this group to support their management in primary care. It is not a substitute for detailed information about peripheral neuropathy, or causes of lower limb numbness.

 

Is tingling in the feet usually peripheral polyneuropathy?

Sometimes, but there are many other causes. Lumbosacral radiculopathy commonly causes paraesthesia in the feet, as does compression of the peroneal nerve at the fibular head. People with restless legs syndrome commonly complain of burning feet and individuals who hyperventilate may experience intermittent paraesthesia in their feet. Neuropathies tend to cause persistent (if variable) symptoms, not intermittent. If people can identify times when their extremities are normal, a neuropathy is unlikely as intermittent sensory symptoms are common in the normal population.

 

Which groups of patients can be managed in primary care with suspected peripheral neuropathy without needing to see a neurologist?

Over the age of 60, around a third of people lose vibration sense at the big toe and around 20% of people lose their ankle reflexes. Approximately 13% of the UK population over the age of 80 probably have some degree of polyneuropathy – which is nearly all axonal. We cannot, and do not, need to see all of these individuals so it is a case of doing what is reasonable and providing sensible advice.

Patients with the following features can usually be managed conservatively in primary care:

  • Symmetrical
  • Distal sensory loss only
  • No gait disturbance
  • Normal neurological examination or only minimal features (e.g. reduced vibration sense at toes)
  • Only very slowly progressive
  • Over the age of 75

This is just a guide and it is difficult to make fixed rules. Please seek our advice if unsure.

 

Which blood tests should these patients have?

  • U&E, FBC, LFTs, TFTs, ESR
  • Blood glucose. Some also suggest doing (and acting on) a glucose tolerance test as well
  • Vitamin B12
  • Protein electrophoresis and serum immunoglobulins
  • HIV

 

What should I tell my patients if I am not referring them?

In an older person with mild sensory distal symptoms as above who you have already investigated, we suggest:

  • Consider treating low normal B12 with replacement therapy
  • In addition, advise the patient that disability is unlikely: e.g. ‘This is common in the population. Its annoying, but is unlikely to progress and cause disability’. Most people with peripheral neuropathy present because they are worried that the problems are going to progress to cause disability and loss of independence. Studies following people for 10 years do not show disability or problems walking.
  • Review for progression: e.g. ‘Come back and see me if problems are worsening or causing mobility problems.’

 

Should I try neuropathic pain medication (e.g. tricyclics, gabapentinoids, duloxetine) for pins+needles / tingling?

Generally, the answer is no. These drugs are for neuropathic pain, not sensory symptoms and they have side effects. They may be useful in moderate to severe symptoms where pain is the issue, but they rarely help non-painful sensory symptoms.

 

References

Based on:

Overell JR. Peripheral neuropathy: pattern recognition for the pragmatist. Pract Neurol. 2011 Apr;11(2):62-70. DOI: 10.1136/jnnp.2011.241612

 

Editorial Information

Last reviewed: 20/12/2024

Next review date: 17/12/2027

Author(s): Centre for Sustainable Delivery.

Version: 2